Administration of this particular exogenous glycoprotein stimulates the cells of the bone marrow to produce more of this particular type of white blood cells which will be helpful in combating potential infections.
This medicine is mainly used in patients who are undergoing treatment for cancer, and have a reduced count of white blood cells, which puts them at risk of developing an infection. It reduces the time period during which the patients are neutropenic, that is, they have a low neutrophil (a type of white blood cell) count.
This medicine could either be administered intravenously or via a subcutaneous injection. Possible adverse effects include a significant fall in the platelet count which could lead to unexplained bleeding or bruising, nausea, bone aches and fever. Patients may also experience tenderness or redness at the site of injection.
Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a Hematologist before using this medicine.
